Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 16.53M | 19.28M | 22.85M | 26.25M | 28.69M | 32.37M | 21.61M | 25.35M | 27.69M | 31M | 28.79M | 33.11M | 39.06M | 47.65M | 53.08M | 61.43M | 69.8M | 77.62M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 40.67K | 40.42K | 40.17K | 41.54K | 41.26K | 40.99K | 40.72K | 40.45K | 40.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 271.16K | 271.16K | 281.66K | 281.66K | 271.16K | n/a | n/a | n/a | n/a | n/a | n/a | 29.35K | 29.36K | 29.37K | n/a | 29.38K | 29.38K | 29.38K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 395.01K | 558.69K | 726.25K | 234.19K | 865.09K | 698.86K | 914.27K | 286.26K | 953.67K | 1.02M | 1.37M | 361.18K | 1.4M | 2.39M | 3.51M | 750.93K | 1.49M | 2.47M |
Total Current Assets | 16.93M | 19.83M | 23.58M | 26.48M | 29.56M | 33.07M | 22.52M | 25.64M | 28.64M | 32.02M | 30.15M | 33.47M | 40.46M | 50.04M | 56.58M | 62.18M | 71.3M | 80.08M |
Property-Plant & Equipment | 70.67K | 76.09K | 81.52K | 86.95K | 92.38K | 90.18K | 88.36K | 86.2K | 1.69K | 1.91K | 2.32K | 118.77K | 191.22K | 262.77K | 239.05K | 276.15K | 222.05K | 281.77K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 382.5K | 387.67K | 403.35K | 410.15K | 404.8K | 131.17K | 129.08K | 126.65K | 41.87K | 1.91K | 2.32K | 148.13K | 220.58K | 292.14K | 239.05K | 305.53K | 251.43K | 311.15K |
Total Assets | 17.31M | 20.22M | 23.98M | 26.89M | 29.96M | 33.2M | 22.65M | 25.77M | 28.68M | 32.02M | 30.16M | 33.62M | 40.68M | 50.34M | 56.82M | 62.48M | 71.55M | 80.39M |
Account Payables | 1.2M | 1.28M | 1.35M | 1.15M | 964.33K | 1.32M | 1.67M | 862.55K | 1.13M | 826.03K | 842.75K | 1.14M | 3.99M | 1.99M | 1.77M | 2.55M | 2.36M | 3.46M |
Deferred Revenue | n/a | n/a | n/a | n/a | 50.74K | 148.41K | 528.97K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 110.55K | 189.12K | 219.5K | 190.47K | 224K | 199.22K | 225.54K |
Other Current Liabilities | 1.55M | 388.97K | 465.01K | 673.32K | 1.5M | 1.21M | 1.17M | 2.26M | 1.54M | 1.67M | 960.36K | 1.46M | 1.64M | 3.72M | 3.74M | 4.93M | 6.97M | 6.75M |
Total Current Liabilities | 3.17M | 3.36M | 3.36M | 3.64M | 3.09M | 2.97M | 4.39M | 4.17M | 3.95M | 4.23M | 3.2M | 4M | 7.68M | 6.72M | 7.32M | 9.04M | 10.6M | 11.21M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 727.36K | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | n/a | 1.31M | 1.31M | 3M | 68.78M | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 727.36K | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M | 3M | 68.78M | 28.06K | 1.96M | 29.77K | n/a | 33.76K |
Total Liabilities | 3.9M | 4.67M | 4.67M | 4.95M | 3.09M | 2.97M | 4.39M | 5.48M | 5.26M | 5.54M | 4.51M | 7M | 76.46M | 6.75M | 7.32M | 9.07M | 10.6M | 11.25M |
Total Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 110.55K | 189.12K | 247.56K | 190.47K | 253.77K | 199.22K | 259.3K |
Common Stock | 5.75K | 5.51K | 5.48K | 5.43K | 5.43K | 5.43K | 3.74K | 3.74K | 3.73K | 3.73K | 2.65K | 52.24K | 23.4K | 21.97K | 21.86K | 21.36K | 21.19K | 21.19K |
Retained Earnings | -328.21M | -324.97M | -321.04M | -318.15M | -314.36M | -310.89M | -308.08M | -304.64M | -301.44M | -298.18M | -293.8M | -291.35M | -287.33M | -189.07M | -181.13M | -173.38M | -163.93M | -153.68M |
Comprehensive Income | -10.63M | -10.63M | -10.63M | -10.6M | -10.63M | -10.63M | -10.61M | -10.64M | -10.63M | -10.56M | -10.62M | -10.24M | -10.27M | -10.42M | -10.36M | -10.45M | -10.25M | -10.44M |
Shareholders Equity | 14.14M | 15.55M | 20.62M | 23.26M | 26.87M | 30.23M | 18.26M | 20.29M | 23.42M | 26.48M | 25.64M | 26.63M | -35.78M | 43.59M | 49.51M | 53.42M | 60.95M | 69.15M |
Total Investments | 40.67K | 40.42K | 40.17K | 41.54K | 41.26K | 40.99K | 40.72K | 40.45K | 40.18K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |